Overview - PubMed (original) (raw)
Review
In: Nicotinic Acetylcholine Receptor Signaling in Neuroprotection [Internet]. Singapore: Springer; 2018. Chapter 1.
2018 Apr 4.
Affiliations
- PMID: 31314411
- Bookshelf ID: NBK543551
- DOI: 10.1007/978-981-10-8488-1_1
Free Books & Documents
Review
Overview
Akinori Akaike et al.
Free Books & Documents
Excerpt
The nicotinic acetylcholine receptor (nAChR) is a typical ion channel type receptor. nAChR agonists such as nicotine evoke rapid excitatory responses in order of milliseconds. In addition to acute responses, sustained stimulation of nAChRs induces delayed cellular responses leading to neuroprotection via intracellular signal pathways probably triggered by Ca2+ influx. The most predominant subtypes of nAChRs expressed in the central nervous system (CNS) are α4 (known as α4β2) and α7 nAChRs. Long-term exposure to nicotine or acetylcholinesterase (AChE) inhibitors exerts protection against neurotoxicity induced by glutamate, β-amyloid, and other toxic insults. Nicotinic neuroprotection is mediated by α7 nAChR which shows high Ca2+ permeability, though contribution of α4 nAChR to nicotinic neuroprotection has also been suggested. Agonist stimulation of these receptors leads to activation of the phosphoinositide 3-kinase (PI3K)-Akt signaling pathway, downstream of neurotrophin receptors. AChE inhibitors including donepezil which is used for treatment of Alzheimer’s disease, also activate PI3K-Akt pathway via nAChRs. Neuroprotective effects induced by long-term nAChR stimulation indicate that CNS nAChRs play important roles in promotion of neuronal survival under pathophysiological conditions such as brain ischemia and neurodegenerative diseases. Elucidation of neuroprotective mechanisms of nAChRs may enable development of novel therapies for neurodegenerative diseases.
Copyright 2018, The Author(s).
Sections
- 1.1. Introduction
- 1.2. Structural and Pharmacological Characterization of Nicotinic Acetylcholine Receptors
- 1.3. Neuroprotection Mediated by Nicotinic Acetylcholine Receptors
- 1.4. Intracellular Signal Transduction Triggered by Nicotinic Acetylcholine Receptors
- 1.5. Acetylcholinesterase Inhibitors Used for Treatment of Alzheimer’ Disease
- 1.6. Conclusion
- References
Similar articles
- Mechanisms of neuroprotective effects of nicotine and acetylcholinesterase inhibitors: role of alpha4 and alpha7 receptors in neuroprotection.
Akaike A, Takada-Takatori Y, Kume T, Izumi Y. Akaike A, et al. J Mol Neurosci. 2010 Jan;40(1-2):211-6. doi: 10.1007/s12031-009-9236-1. J Mol Neurosci. 2010. PMID: 19714494 Review. - Nicotinic Acetylcholine Receptor Signaling: Roles in Neuroprotection.
Kume T, Takada-Takatori Y. Kume T, et al. 2018 Apr 4. In: Akaike A, Shimohama S, Misu Y, editors. Nicotinic Acetylcholine Receptor Signaling in Neuroprotection [Internet]. Singapore: Springer; 2018. Chapter 4. 2018 Apr 4. In: Akaike A, Shimohama S, Misu Y, editors. Nicotinic Acetylcholine Receptor Signaling in Neuroprotection [Internet]. Singapore: Springer; 2018. Chapter 4. PMID: 31314407 Free Books & Documents. Review. - Neuroprotection by donepezil against glutamate excitotoxicity involves stimulation of alpha7 nicotinic receptors and internalization of NMDA receptors.
Shen H, Kihara T, Hongo H, Wu X, Kem WR, Shimohama S, Akaike A, Niidome T, Sugimoto H. Shen H, et al. Br J Pharmacol. 2010 Sep;161(1):127-39. doi: 10.1111/j.1476-5381.2010.00894.x. Br J Pharmacol. 2010. PMID: 20718745 Free PMC article. - Astrocytic α7 Nicotinic Receptor Activation Inhibits Amyloid-β Aggregation by Upregulating Endogenous αB-crystallin through the PI3K/Akt Signaling Pathway.
Ren Z, Yang M, Guan Z, Yu W. Ren Z, et al. Curr Alzheimer Res. 2019;16(1):39-48. doi: 10.2174/1567205015666181022093359. Curr Alzheimer Res. 2019. PMID: 30345917 - Roles of Nicotinic Acetylcholine Receptors in the Pathology and Treatment of Alzheimer’s and Parkinson’s Diseases.
Shimohama S, Kawamata J. Shimohama S, et al. 2018 Apr 4. In: Akaike A, Shimohama S, Misu Y, editors. Nicotinic Acetylcholine Receptor Signaling in Neuroprotection [Internet]. Singapore: Springer; 2018. Chapter 8. 2018 Apr 4. In: Akaike A, Shimohama S, Misu Y, editors. Nicotinic Acetylcholine Receptor Signaling in Neuroprotection [Internet]. Singapore: Springer; 2018. Chapter 8. PMID: 31314416 Free Books & Documents. Review.
References
- Aizenman E, Tang LH, Reynolds IJ (1991) Effects of nicotinic agonists on the NMDA receptor. Brain Res 551:355–357 - PubMed
- Akaike N, Harata N, Tateishi N (1991) Modulatory action of cholinergic drugs on N-methyl-D-aspartate response in dissociated rat nucleus basalis of Meynert neurons. Neurosci Lett 130:243–247 - PubMed
- Akaike A, Tamura Y, Yokota T et al (1994) Nicotine-induced protection of cultured cortical neurons against N-methyl-D-aspartate receptor-mediated glutamate cytotoxicity. Brain Res 644:181–187 - PubMed
- Akaike A, Takada-Takatori Y, Kume T et al (2010) Mechanisms of neuroprotective effects of nicotine and acetylcholinesterase inhibitors: role of α4 and α7 receptors in neuroprotection. J Mol Neurosci 40:211–216. https://doi.org/10.1007/s12031-009-9236-1 - DOI - PubMed
- Albuquerque EX, Santos MD, Alkondon M (2001) Modulation of nicotinic receptor activity in the central nervous system: a novel approach to the treatment of Alzheimer disease. Alzheimer Dis Assoc Disord 5(Suppl 1):S19–S25 - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous